Evidence map›Paper›PMID 42824941›Full record

ArticleTobacco prevention & cessation2026

Predictors of cigarette discontinuation and reduction among adults never planning to quit smoking: Longitudinal findings from the U.S. Population Assessment of Tobacco and Health (PATH) study, 2014/15-2021.

Karin A Kasza, Martin C Mahoney, Andrew Anesetti-Rothermel, Heather L Kimmel, Eva Sharma, K Michael Cummings, Adam F Benson, Willa Dong, Kathryn C Edwards, Daniela Marshall and 7 more

Abstract read
In one paragraph

Article in Tobacco prevention & cessation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Karin A KaszaDepartment of Health Behavior Roswell Park Comprehensive Cancer Center Buffalo United States.
Martin C MahoneyDepartment of Health Behavior Roswell Park Comprehensive Cancer Center Buffalo United States.
Andrew Anesetti-RothermelOffice of Science, Center for Tobacco Products, Food and Drug Administration Silver Spring United States.
Heather L KimmelDivision of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, National Institutes of Health Bethesda United States.
Eva SharmaPublic Health, Westat Rockville United States.
K Michael CummingsDepartment of Psychiatry and Behavioral Sciences Medical University of South Carolina Charleston United States.
Adam F BensonOffice of Science, Center for Tobacco Products, Food and Drug Administration Silver Spring United States.
Willa DongOffice of Science, Center for Tobacco Products, Food and Drug Administration Silver Spring United States.
Kathryn C EdwardsPublic Health, Westat Rockville United States.
Daniela MarshallAxle Informatics Rockville United States.
Lauren R PacekOffice of Science, Center for Tobacco Products, Food and Drug Administration Silver Spring United States.
Jacqueline ReubenOffice of Science, Center for Tobacco Products, Food and Drug Administration Silver Spring United States.
Mark RinellaOffice of Science, Center for Tobacco Products, Food and Drug Administration Silver Spring United States.
Candrea SmithOffice of Science, Center for Tobacco Products, Food and Drug Administration Silver Spring United States.
Wondimu TekaOffice of Science, Center for Tobacco Products, Food and Drug Administration Silver Spring United States.
Dorothy HatsukamiDepartment of Psychiatry and Behavioral Sciences Masonic Cancer Center, University of Minnesota Minneapolis United States.
Andrew HylandDepartment of Health Behavior Roswell Park Comprehensive Cancer Center Buffalo United States.

Funding

Rutgers Center of Excellence in Rapid Surveillance of TobaccoU01CA278695 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI CRISTINE D DELNEVO, Ollie Ganz · 2023 to 2026
$14.0M
NCI NIH HHS U01 CA278695NIDA NIH HHS HHSN271201100027CNIH HHS HHSN271201600001C
6 · The paper itself

Abstract

Introduction: E-cigarettes have increased in use prevalence among adults who smoke cigarettes. However, the population-based literature on e-cigarette use and smoking cessation largely still focuses on those planning or attempting to quit smoking. We evaluated predictors of cigarette discontinuation or reduction among adults not planning to ever quit smoking. Methods: We conducted secondary data analyses using the Population Assessment of Tobacco and Health (PATH) Study (2014-2021; Waves 2-6) cohort data collected in the United States. Data were collected using audio computer-assisted in-person or telephone self-interviews. Participants were aged ≥21 years who smoked cigarettes every day, did not plan to ever quit smoking, and did not use e-cigarettes at baseline assessment. Predictors were previous quit attempt, quitting interest, nicotine dependence, cigarette pack-years, e-cigarette uptake (none, non-daily, daily uptake), e-cigarette flavor (tobacco, menthol/mint, fruit/sweet/other, combination flavors), e-cigarette device type (disposable, cartridge, tank/mod). Outcomes were cigarette discontinuation (from daily to no smoking) and cigarette reduction (from daily to non-daily smoking) among those who did not discontinue smoking. Weighted and adjusted generalized estimating equation logistic regression analyses were conducted. Results: Assessment in 2018/19-2021 (vs 2014/15-2015/16) was associated with higher odds of cigarette reduction (adjusted odds ratio, AOR=2.32; 95% CI: 1.01-5.36). Higher nicotine dependence (vs lower) was associated with lower odds of cigarette reduction (2.3% vs 6.7%, AOR=0.48; 95% CI: 0.25-0.90). Uptake of daily e-cigarette use (vs no uptake) was associated with reducing or discontinuing cigarette smoking (53.5% vs 10.0%, AOR=14.58; 95% CI: 5.99-35.50); the rate of daily e-cigarette uptake was 2%. Conclusions: Uptake of daily e-cigarette use was associated with cigarette reduction/discontinuation among people who smoked daily and did not plan to ever quit. Findings add to growing evidence on the role of e-cigarettes in moving adults who smoke down the continuum of risk, particularly among an understudied population at high risk of smoking-attributable morbidity and mortality.

Indexed as

cessationcigarettese-cigarettesintentionspopulation

Identifiers

PMID42824941
PMCPMC13628602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.